Cost considerations for clinicians prescribing biologic drugs: Who pays?

Affiliations

¹ Ambulatory Care Department of Pharmacy, Penn Presbyterian Medical Center, University of Pennsylvania, Philadelphia, Pa.
² Section of Allergy & Immunology, Division of Pulmonary, Allergy, & Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa.
³ Section of Allergy & Immunology, Division of Pulmonary, Allergy, & Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa. Electronic address: Andrea.Apter@pennmedicine.upenn.edu.

Editorial

Christopher Hvisdas et al. J Allergy Clin Immunol. 2020 Aug.

. 2020 Aug;146(2):266-269.

doi: 10.1016/j.jaci.2020.03.033. Epub 2020 Apr 20.

¹ Ambulatory Care Department of Pharmacy, Penn Presbyterian Medical Center, University of Pennsylvania, Philadelphia, Pa.
² Section of Allergy & Immunology, Division of Pulmonary, Allergy, & Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa.
³ Section of Allergy & Immunology, Division of Pulmonary, Allergy, & Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa. Electronic address: Andrea.Apter@pennmedicine.upenn.edu.

No abstract available

Keywords: Asthma; biologic drugs; pharmacy benefit manager; specialty drugs; specialty pharmacy.

Publication types